Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis

作者
Fiorenzo Santoleri,Paola Sorice,Ruggero Lasala,Rosa Carmela Rizzo,Alberto Costantini
出处
期刊:Journal of Medical Economics [Informa]
卷期号:17 (5): 320-325 被引量:9
标识
DOI:10.3111/13696998.2014.902844
摘要

OBJECTIVE: The aim of this study was to evaluate medication adherence and persistence of patients treated with Etanercept and Adalimumab for Rheumatoid Arthritis, also giving economic evaluations on therapy costs for Received Daily Dose (RDD). MATERIALS AND METHODS: This retrospective study took into account 6 years from January 1, 2007 to December 31, 2012. Medication adherence was quantified utilizing the ratio between RDD and Prescribed Daily Dose (PDD). Persistence has been reckoned taking into account the actual days of therapy comparing posology with supplied dose. The persistence has been graphed according to Kaplan-Meier method. The cost per RDD was reckoned starting from the expense incurred by Pescara General Hospital. RESULTS: Medication adherence gave results in values between 0.88-0.97 for Etanercept and 0.83-0.90 for Adalimumab. The value of persistence was 100% for Etanercept and 90% for Adalimumab for the first year, and 70% for Etanercept and 80% for Adalimumab for the second year. In the 3rd year the persistence for Etanercept was 50% while for Adalimumab it was 60%. In the fourth year the persistence for Etanercept was 21% while for Adalimumab it was 27%. The statistical analysis was conducted using the Log rank test. The average cost per RDD was €32.97 for Etanercept and for Adalimumab it was €32.00 as an average of 6 years. CONCLUSION: The medication adherence was good for both Etanercept and Adalimumab. The rate of persistence decreased strictly in the fourth year of treatment. This data suggests the need for continuous monitoring of patients in treatment with TNF blockers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
Karry爱科研完成签到,获得积分10
3秒前
huaner发布了新的文献求助10
4秒前
冷傲凝琴完成签到,获得积分10
5秒前
5秒前
xushengyang发布了新的文献求助10
6秒前
田様的应助被起床做核酸采纳,获得100
6秒前
隐形曼青的应助被Jeremy采纳,获得10
6秒前
无私芮完成签到 ,获得积分10
6秒前
leo发布了新的文献求助10
6秒前
6秒前
7秒前
Agoni发布了新的文献求助10
7秒前
MM发布了新的文献求助10
7秒前
Fmx发布了新的文献求助20
7秒前
GIN的应助被Apple采纳,获得10
7秒前
12完成签到 ,获得积分10
8秒前
宽kuan完成签到 ,获得积分10
10秒前
linkeral完成签到,获得积分20
11秒前
12秒前
听暮雪完成签到,获得积分20
12秒前
dh发布了新的文献求助10
13秒前
坚定啤酒发布了新的文献求助10
13秒前
Heyouatpome完成签到,获得积分10
13秒前
13秒前
科研通AI6.3的应助被wuliweiwei采纳,获得10
14秒前
14秒前
qky发布了新的文献求助10
15秒前
15秒前
17秒前
scfsl完成签到,获得积分10
17秒前
年轻元冬完成签到,获得积分10
18秒前
18秒前
MM完成签到,获得积分20
18秒前
Fmx完成签到,获得积分10
19秒前
zvvZB发布了新的文献求助10
19秒前
19秒前
20秒前
起床做核酸发布了新的文献求助100
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192841
求助须知:如何正确求助?哪些是违规求助? 9579236
关于积分的说明 21864289
捐赠科研通 7792410
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483927